Biogen
Morasa Sheikhy, PharmD, PhD is a clinical pharmacologist with over a decade of experience spanning industry, regulatory, academic, and clinical settings. Currently a Principal Scientist at Biogen, she leads clinical pharmacology strategy and execution for lifecycle management and early-phase development of multiple sclerosis therapies. Her work includes designing pediatric, ethnic sensitivity, and bioequivalence studies, as well as conducting advanced PK/PD analyses.
Previously, Dr. Sheikhy served as an ORISE Fellow at the FDA, where she contributed to regulatory guidance on biosimilars and biologics by identifying viable pharmacodynamic biomarkers and drafting policy briefs. Her research background includes collaborative work on bioequivalence studies using microdialysis at Long Island University, where she also earned her PhD in Pharmaceutics. Her expertise spans clinical trial design, regulatory submissions, and quantitative pharmacology, supported by her proficiency with tools like Phoenix WinNonlin, SimCyp, R, and NONMEM.
Dr. Sheikhy brings a global and interdisciplinary perspective to her work, having begun her career as a pharmacist and drug information specialist. She remains committed to mentoring the next generation of scientists and contributing to scientific literature through ongoing manuscript development.